Results 1 to 10 of about 70,632 (244)

Peripheral neuropathy associated with tofacitinib use in alopecia universalis

open access: yesJournal of Dermatology and Dermatologic Surgery, 2022
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. Alopecia universalis (AU) is the advanced form of AA characterized by complete scalp and body hair loss.
Raghad Alharthi   +4 more
doaj   +1 more source

Generation of Janus kinase 1 (JAK1) conditional knockout mice [PDF]

open access: yesgenesis, 2016
AbstractThe biological functions of the Janus kinase 1 (JAK1) are suggested to be pleiotropic since this signal transducer is ubiquitously expressed and coupled to a variety of cytokine receptors. Consequently, mice that are deficient in this tyrosine kinase were reported to die shortly after birth. To facilitate studies that address the biological and
Kazuhito, Sakamoto   +4 more
openaire   +2 more sources

Janus kinase inhibitors: jackpot or potluck?

open access: yesOncology Reviews, 2012
The reports of a unique mutation in the Janus kinase-2 gene (JAK2) in polycythemia vera by several independent groups in 2005 quickly spurred the development of the Janus kinase inhibitors.
Pavithran Keechilat   +1 more
doaj   +1 more source

Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition

open access: yesJEADV Clinical Practice, 2022
Pyoderma gangrenosum (PG) is a rare, autoinflammatory disease leading to painful, hard‐to‐treat ulcers. Besides systemic glucocorticoids, a plethora of classic immunosuppressants, biologics and small molecules have been reported to improve PG disease ...
Sebastian Sitaru   +2 more
doaj   +1 more source

Constitutive nuclear localization of Janus kinases 1 and 2. [PDF]

open access: yesEndocrinology, 1996
Both GH and the GH receptor have been reported to undergo rapid nuclear translocation. Janus kinases (JAK) 1 and 2 have been implicated in GH receptor signaling, and both of these kinases are phosphorylated by GH stimulation. In this report, we have investigated the subcellular distribution of JAK1 and JAK2.
Lobie, P.E.   +5 more
openaire   +2 more sources

Changes of Signaling Pathways in Hypothalamic Neurons with Aging

open access: yesCurrent Issues in Molecular Biology, 2023
The hypothalamus is an important regulator of autonomic and endocrine functions also involved in aging regulation. The aging process in the hypothalamus is accompanied by disturbed intracellular signaling including insulin/insulin-like growth factor-1 ...
Petr M. Masliukov
doaj   +1 more source

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia

open access: yesHaematologica, 2011
Background Prognostic risk stratification according to acquired or inherited genetic alterations has received increasing attention in acute myeloid leukemia in recent years.
Sarolta Nahajevszky   +18 more
doaj   +1 more source

Association of Janus kinase 1 and 2 expression with clinical indices in diabetic kidney disease

open access: yesJournal of Research in Medical Sciences
Background: Diabetic Kidney Disease (DKD) is a prevalent complication of uncontrolled hyperglycemia that imposes a considerable burden on the health system due to the need for renal replacement therapy in the long term.
Mahboobeh Freidoon   +8 more
doaj   +1 more source

Clinical-economic analysis of the target therapy in severe atopic dermatitidis in adults

open access: yesКачественная клиническая практика, 2022
Target therapy of severe atopic dermatitidis (AD) is actual because AD has a high prevalence and social-economic burden. Target therapy consists of monoclonal antibodies (dupilumab) as well as janus kinase inhibitors (upadacitinib and baricitinib).
A. S. Kolbin   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy